Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares (IINN)

FairStock Score: 25/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At the close on 2026-07-17, Inspira traded at $1.26, giving a market capitalization of $23.5 million. FairStock’s calculations show a negative P/E of -2.80 and a price-to-book ratio of 18.00. Return on equity is -397.89% and return on capital employed is -126.98%, so the business is destroying capital, not compounding it. The debt-to-equity ratio of 0.21 is not alarming, but the Piotroski F-Score of 0/9 and Altman Z-Score of -15.88 point to severe financial weakness. The FairStock score is 25/100. The company has 34 employees and offers INSPIRA ART100 for short cardiopulmonary bypass and the HYLA blood sensor. Those are interesting medical-device concepts, but the data provides no revenue growth figure, no profit growth figure, and no multi-year filed results. The Lynch category is none because only 0 years of filed results are available; three are needed. A medical-device moat comes from approvals, clinical evidence, reimbursement, and adoption, none of which can be verified here. With a beta of 2.16 and a 52-week range of $0.28 to $3.85, the shares are highly speculative. Graham would ask for a margin of safety; at 18 times book with negative earnings, there is none. Buffett would want durable economics and a long runway of earnings. I see a small, early-stage company with a large option value but no demonstrated value-investing case yet.

In plain English: Inspira Technologies is a small Israeli medical device company that offers products for breathing support and blood monitoring. The business looks weak right now: it is not profitable, has very poor returns on its capital, and shows high risk of financial distress. At $1.26 a share, the price looks expensive compared with its accounting value and is not supported by earnings.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-07-17 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer